Glutathione
Also known as: L-Glutathione, GSH, Reduced Glutathione, γ-L-glutamyl-L-cysteinyl-glycine
Popular For
Detoxification, antioxidant support, skin health, anti-aging
Key Facts: Glutathione
- Category
- Anti-Aging
- FDA Status
- Not FDA Approved
- Clinical Status
- GRAS Status (Generally Recognized As Safe) - Extensive Human Research
- Administration
- Oral, liposomal, IV, or subcutaneous
- Typical Dose
- 500-1000 mg daily (oral or liposomal)
- Frequency
- 1-2x daily
- Evidence Level
- Human Trials
- Duration
- Ongoing supplementation or 4-12 week courses
Mechanism of Action
Glutathione directly neutralizes free radicals including superoxide, hydroxyl radicals, and nitric oxide. It regenerates other antioxidants like vitamins C and E. Through glutathione peroxidase enzymes, it detoxifies peroxides and lipid peroxides. The GSH/GSSG ratio (typically >100:1 in healthy cells) determines cellular redox status. Also critical for Phase II liver detoxification, binding toxins for excretion.
Research Summary
Extensive research across multiple therapeutic areas. Clinical trials show benefits for liver health, skin lightening (via melanin modulation), neurodegenerative conditions, and immune support. FDA grants GRAS status for food use. Studies on Parkinson's patients showed symptom improvement with IV administration. Liposomal forms show improved bioavailability in clinical studies.
Dosing Information
Typical Dosingⓘ
Community experience
500-1000 mg daily (oral or liposomal)
250-2000 mg daily depending on form
1-2x daily
Liposomal forms show better absorption than standard oral. IV provides rapid increases but effects fade after ~2 months. N-acetyl cysteine (NAC) is an alternative to boost endogenous GSH production. Consider with vitamin C for enhanced recycling.
Research Dosingⓘ
Scientific studies
Multiple administration routes available
Doses from Studies
500 mg oral twice daily for 6 months
Clinical Trial - Randomized controlled trial on GSH supplementation ↗
500-1000 mg liposomal daily
Clinical Trial - Liposomal GSH pilot study showing 40% blood level increase ↗
1400 mg IV 3x weekly for 4 weeks
Clinical Trial - Parkinson's disease symptom improvement study ↗
Duration
Ongoing supplementation or 4-12 week courses
Administration
Oral, liposomal, IV, or subcutaneous
Timing & Administration
Best Time to Take
Morning on empty stomach, or evening
Once or twice daily
Food Recommendation
Take on empty stomach
Why This Timing?
Absorption may be improved on empty stomach. Some prefer evening to support overnight detoxification and cellular repair processes.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Generally well-tolerated
- ●Oral: bloating, mild cramping, gas
- ●Oral: loose stools in some users
- ●IV: injection site reactions
- ●IV: rare cases of hepatotoxicity reported
- ●IV: FDA warns of potential contamination risks with compounded forms
- ●May cause flushing
- ●Potential weight gain (rare)
- ●Inhaled form may exacerbate asthma
References
Related Peptides
Peptides commonly compared with Glutathione or used in similar applications.
DSIP
Clinical TrialsA neuropeptide that promotes deep delta wave sleep. First isolated from rabbit brains in 1977. Used for sleep optimization and stress reduction.
Anti-AgingHumanin
PreclinicalA mitochondria-derived peptide discovered for its neuroprotective effects against Alzheimer's-related toxicity. Being studied for aging and metabolic benefits.
Anti-AgingNAD+ Precursors
Clinical TrialsWhile not peptides, NAD+ precursors are frequently discussed alongside peptides in longevity circles. They boost cellular NAD+ levels, supporting energy metabolism and sirtuin activity.
Anti-AgingSS-31
FDAA mitochondria-targeted peptide that improves cellular energy production. FDA approved for Barth syndrome (September 2025) as FORZINITY, the first approved mitochondria-targeted therapeutic.
Anti-AgingFOXO4-DRI
PreclinicalA senolytic peptide designed to selectively eliminate senescent 'zombie' cells by disrupting the FOXO4-p53 interaction. Shows promise for restoring tissue function in aging, including kidney health restoration.
Anti-AgingVesilute
PreclinicalA synthetic dipeptide (Glu-Asp) bioregulator from the Khavinson peptide family, studied for urinary tract and prostate support. Research suggests it may help with bladder function and prostate microcirculation. Part of the tissue-specific bioregulatory compounds developed over 40+ years of research.
Anti-AgingLooking for a trusted vendor?
Pro members get access to verified vendors with quality standards & exclusive discount codes.
Want updates on Glutathione research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.